|
⚲
|
| Keyboard |
| Stephen Cunningham | |
|---|---|
| Firm | |
| Address | c/o Chase Pharmaceuticals Corp 1825 K Street, NW Suite 510 Washington, DC 20006 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Chase Pharmaceuticals Corp | 021-260084 | Director | 12.0 M of 12.0 M |
||
| Chase Pharmaceuticals Corp | 021-257591 | Director | of 0.1 M |
||
| Chase Pharmaceuticals Corp | 021-257589 | Director | of 0.6 M |
||
| Chase Pharmaceuticals Corp | 021-246193 | Director | 3.5 M of 3.5 M |
||
| Varvee Inc | 021-137380 | Executive Officer | 0.6 M of 1.5 M |
||